Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 283, Issue 5 52-5, 2002, Pages

  Bertram, Delphine ^a   Blanc Brunat, Nelly ^b   Sassard, Jean ^a   Lo, Ming ^a  

^a CNRS   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Angiotensin converting enzyme; Glomerulosclerosis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RAT STRAIN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINARY EXCRETION;

EID: 0036839555     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00620.2001     Document Type: Article

References (32)

1. Bertolino S, Julien C, Medeiros IA, Cuisinaud G, Vincent M, and Barrbs C. Renin secretion in conscious Lyon hypertensive rats. Am J Physiol Regul Integr Comp Physiol 271: R1199-R1204, 1996.
2. Blanc-Brunat N, Vincent M, and Sassard J. Development of early kidney lesions in genetically hypertensive, normotensive and hypotensive rats. Paroi Artérielle/Arterial Wall 6: 145-154, 1980.
3. Christensen HRL, Nielsen H, Christensen KL, Baandrup U, Jespersen LT, and Mulvany MJ. Long-term hypotensive effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: Is there a role for vascular structure? J Hypertens 6, Suppl 3: S27-S31, 1988.
4. Christensen KL, Jespersen LT, and Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens 7: 83-90, 1989.
5. Dukacz SAW, Adams MA, and Kline RL. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats. Am J Physiol Renal Physiol 273: F104-F112, 1997.
6. Dukacz SAW, Feng MG, Yang LF, Lee RMKW, and Kline RL. Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment. Am J Physiol Regul Integr Comp Physiol 280: R1076-R1084, 2001.
7. Florin M, Lo M, and Sassard J. Effects of fetal and neonatal renin-angiotensin system blockade in Lyon hypertensive rats. J Cardiovasc Pharmacol 33: 549-553, 1999.
8. Freslon JL and Giudicelli JF. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol 80: 533-543, 1983.
9. Frey BAJ, Grisk O, Bandelow N, Wussow S, Bie P, and Rettig R. Sodium homeostasis in transplanted rats with a spontaneously hypertensive rat kidney. Am J Physiol Regul Integr Comp Physiol 279: R1099-R1104, 2000.
10. Gustin MP, Cerutti C, and Paultre CZ. Heterogeneous computer network for real-time hemodynamic signal processing. Comput Biol Med 20: 205-215, 1990.
11. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science 252: 1813-1816, 1991.
12. Harrap SB, Nicolaci JA, and Doyle AE. Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril. Clin Exp Pharmacol Physiol 13: 753-765, 1986.
13. Harrap SB, Van der Merwe WM, Griffin SA, MacPherson F, and Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 16: 603-614, 1990.
14. Kost CK Jr, Li P, and Jackson EK. Blood pressure after captopril withdrawal from spontaneously hypertensive rats. Hypertension 25: 82-87, 1995.
15. Lantelme P, Lo M, Luttenauer L, and Sassard J. Pivotal role of the renin-angiotensin system in Lyon hypertensive rats. Am J Physiol Regul Integr Comp Physiol 273: R1793-R1799, 1997.
16. Liu KL, Sassard J, and Benzoni D. In the Lyon hypertensive rat, renal function alterations are angiotensin II dependent. Am J Physiol Regul Integr Comp Physiol 271: R346-R351, 1996.
17. Lo M, Julien C, Barrès C, Medeiros I, Allevard AM, Vincent M, and Sassard J. Blood pressure maintenance in hypertensive sympathectomized rats. II. Renin-angiotensin system and vasopressin. Am J Physiol Regul Integr Comp Physiol 261: R1052-R1056, 1991.
18. Mulvany MJ, Persson AEG, and Andresen J. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J Hypertens 9: 589-593, 1991.
19. Obata J, Nakamura T, Takano H, Naito A, Kimura H, Yoshida Y, Shimizu F, Guo DF, and Inagami T. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 18: 1247-1255, 2000.
20. Oddie CJ, Dilley RJ, Kanellakis P, and Bobik A. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: Effects on vascular structure and reactivity. J Hypertens 11: 717-724, 1993.
21. 1 receptors on glomerular injury in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 274: R1797-R1806. 1998.
22. Richer C, Mulder P, Fornes P, Richard V, Camilleri JP, and Giudicelli JF. Hemodynamic and morphological effects of quinapril during genetic hypertension development. J Cardiovasc Pharmacol 18: 631-642, 1991.
23. Sen S, Smeby RR, and Bumpus FM. Renin in rats with spontaneous hypertension. Circ Res 31: 876-880, 1972.
24. Skov K, Fenger-Gron J, and Mulvany MJ. Effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist, and an endothelin receptor antagonist on renal afferent arteriolar structure. Hypertension 28: 464-471, 1996.
25. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, and Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 23: 659-666, 1994.
26. Unger T, Moursi M, Ganten D, Hermann K, and Lang RE. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: Comparison with enalapril (MK421) and ramipril (Hoe498). J Cardiovasc Pharmacol 8: 276-285, 1986.
27. Vincent M, Dupont J, and Sassard J. Plasma renin activity as a function of age in two new strains of spontaneously hypertensive and normotensive rats. Clin Sci Mol Med 50: 103-107, 1976.
28. Vincent M and Sassard J. Lyon strains. In: Textbook of Hypertension, edited by Swales JD. Oxford: Blackwell Scientific, 1994, p. 455-457.
29. Watanabe N, Kamei S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, and Tokuda K. Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem 32: 1551-1554, 1986.
30. Wong VY, Laping NJ, Contino LC, Olson BA, Grygielko E, and Brooks DP. Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartan. Physiol Genomics 4: 35-42, 2000.
31. Wu JN and Berecek KH. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension 22: 139-146, 1993.
32. Yoshida Y, Kawamura T, Ikoma M, Fogo A, and Ichikawa I. Effects of antihypertensive drugs on glomerular morphology. Kidney Int 36: 626-635, 1989.